|Application ||IP, EIA|
|Immunogen||Adeno-associated virus capsid proteins and virus particles|
|Purification||Protein A chromatography|
|Target/Specificity||Reacts with intact adeno-associated virus particles, empty and full capsids. Recognizes a conformational epitope of assembled capsids that is not present in denatured capsid proteins and native but unassembled capsid proteins.|
|Preservative||0.09% Sodium Azide (prior to lyophilization)|
|Storage||Store (up to 1 year after reconstitution) at 2-8°C.|
|Precautions||Monoclonal Antibody to Adeno-associated Virus (AAV), intact particles [A20] is for research use only and not for use in diagnostic or therapeutic procedures.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The references listed below are for research purposes only.1. Wistuba, A., et al., (1995), “Intermediates of adeno-associated virus type 2 assembly: Identification of soluble complexes containing Rep and Can proteins”, J. Virol., 69. 5311-5319.2. Wistuba, A., et al., (1997), “Subcellular compartmentalization of adeno-associates virus type 2 assembly”, J. Virol., 71, 1341-1352.3. Grimm, D., et al., (1999), “Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2”, Gene Ther. 6(7), 1322-1330.4. Wobus, C.A., (2000), “Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: Epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection”, J. Virology, 74, 9281-9293.
If you have any additional inquiries please email technical services at email@example.com.